期刊导航

论文摘要

2型糖尿病患者血清半乳糖凝聚素-3水平与牙周炎的相关性研究

Association between serum Galectin-3 and periodontitis in patients with type 2 diabetes mellitus

作者:张彦表, 魏美容, 夏天永, 尹文婷, 毛淑梅

Author:Zhang Yanbiao, Wei Meirong, Xia Tianyong, Yin Wenting, Mao Shumei

收稿日期:2023-06-18          年卷(期)页码:2023,41(6):653-653-661

期刊名称:华西口腔医学杂志

Journal Name:West China Journal of Stomatology

关键字:2型糖尿病,半乳糖凝聚素-3,牙周炎,相关性,

Key words:type 2 diabetes mellitus,Galectin-3,periodontitis,association,

基金项目:山东省自然科学基金面上项目(ZR2020MH381);山东省中医药发展计划项目(2019-0436)

中文摘要

目的 探讨血清半乳糖凝聚素-3(Galectin-3)水平与2型糖尿病(T2DM)患者牙周炎发病风险的相关性。 方法 选取2021年7月—2022年11月在潍坊医学院附属潍坊市人民医院内分泌科就诊的T2DM患者140例,根据是否合并牙周炎分为T2DM不伴牙周炎组(T2DM组,n=67)和T2DM伴牙周炎组(T2DMP组,n=73),同期选取口腔科门诊血糖正常的非牙周炎志愿者65例为健康对照组(NC组)。采集所有受试者血液标本,检测并比较3组血清Galectin-3水平及相关实验室指标。 结果 NC组、T2DM组和T2DMP组血清Galectin-3水平分别为3.81(3.49,4.15)、4.82(4.25,5.26)和6.83(5.19,7.28)ng/mL,采用多元线性回归模型校正基线资料影响后,T2DMP组和T2DM组血清Galectin-3水平比NC组显著升高(均P<0.05)。多元线性回归分析结果显示,血清Galectin-3水平与稳态模型胰岛素抵抗指数(β=0.254,95%CI:0.089~0.419,P=0.003)、糖化血红蛋白A1c(β=0.397,95%CI:0.049~0.745,P=0.026)和临床附着丧失(β=0.298,95%CI:0.024~0.572,P=0.033)独立正相关。校正协变量影响后,二分类Logistic回归结果显示,血清Galectin-3水平与T2DM患者牙周炎发病风险显著相关(OR=2.146,95%CI:1.260~3.655,P=0.005);趋势检验显示,T2DM患者牙周炎发病风险随着血清Galectin-3三分位数分组水平增加而增加(Ptrend=0.011)。受试者工作特征(ROC)曲线分析显示,血清Galectin-3预测T2DM伴发牙周炎的曲线下面积(AUC)为0.861(95%CI:0.801~0.920,Z=11.806,P<0.001)。 结论 T2DM伴牙周炎患者的血清Galectin-3水平升高;血清Galectin-3水平与T2DM患者牙周炎发病风险存在相关性。

英文摘要

ObjectiveThis study aims to investigate the correlation between serum Galectin-3 levels and the risk of periodontitis in patients with type 2 diabetes mellitus (T2DM).MethodsA total of 140 patients with T2DM admitted to the endocrinology department of Weifang People’s Hospital, Affiliated to Weifang Medical College from July 2021 to November 2022 were selected and divided into T2DM without periodontitis group (T2DM group,n=67) and T2DM with periodontitis group (T2DMP group,n=73) according to whether they were combined with periodontitis. In the same period, 65 non-periodontitis volunteers with normal blood glucose were selected as healthy control group (NC group). Blood samples of all subjects were collected, and serum Galectin-3 levels and related laboratory indices were detected and compared among the three groups.ResultsSerum Galectin-3 levels in the NC, T2DM, and T2DMP groups were 3.81 (3.49, 4.15), 4.82 (4.25, 5.26), and 6.83 (5.19, 7.28) ng/mL, respectively. After adjusting for the influence of baseline data by multiple linear regression, serum Galectin-3 levels in the T2DMP and T2DM groups were significantly higher than those in the NC group (allP<0 .05). multiple linear regression analysis showed that serum galectin-3 levels were positively correlated with homeostatic model of the insulin resistance index (β=0.254, 95%CI:0.089-0.419,P=0.003), glycosylated hemoglobin A1c (β=0.397, 95%CI: 0.049-0.745,P=0.026), and clinical attachment loss (β=0.298, 95%CI: 0.024-0.572,P=0.033). After adjusting for the effects of covariates, binary logistic regression showed that serum Galectin-3 levels were significantly associated with the risk of periodontitis in patients with T2DM (OR=2.146, 95%CI: 1.260-3.655,P=0.005). Trend test showed that the risk of periodontitis in patients with T2DM increased with increasing serum Galectin-3 levels (Ptrend=0.011). Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) of serum Galectin-3 in predicting T2DM periodontitis was 0.861 (95%CI: 0.801-0.920,Z=11.806,P<0 .001).ConclusionSerum Galectin-3 levels were elevated in patients with T2DM and pe-riodontitis and associated with the risk of periodontitis.

关闭

Copyright © 2020四川大学期刊社 版权所有.

地址:成都市一环路南一段24号

邮编:610065